Advertisement · 728 × 90
#
Hashtag
#SciTech_Development
Advertisement · 728 × 90
Preview
SciTech Development Expands Leadership Team with Key Appointments to Enhance Oncology Innovations SciTech Development is strengthening its leadership team with the appointment of Dr. Peter Littrup as Medical Director and Joseph Kraus to the Advisory Board to drive oncology advancements.

SciTech Development Expands Leadership Team with Key Appointments to Enhance Oncology Innovations #United_States #Detroit #SciTech_Development #Peter_Littrup #Joseph_Kraus

0 0 0 0
Preview
SciTech Development Secures $5.5 Million to Advance Cancer Trials with Promising Drug SciTech Development has successfully raised $5.5 million in funding to enhance its cancer clinical trials, showcasing promising results for its innovative drug ST-001.

SciTech Development Secures $5.5 Million to Advance Cancer Trials with Promising Drug #United_States #Detroit #Clinical_Trials #SciTech_Development #nanoFenretinide

0 0 0 0
Preview
SciTech Development Celebrates Second FDA Approval for New Lung Cancer Treatment SciTech Development has received FDA approval for its investigational drug ST-001 aimed at treating relapsed small cell lung cancer, expanding opportunities for patients.

SciTech Development Celebrates Second FDA Approval for New Lung Cancer Treatment #United_States #SciTech_Development #ST-001 #T-Cell_NHL #Grosse_Pointe_Farms

0 0 0 0
Preview
SciTech Development Strengthens Leadership with Dr. Ken Massey as Operations Advisor SciTech Development is pleased to announce Dr. Ken Massey's appointment as Strategic Operations Advisor, enhancing their drug development efforts.

SciTech Development Strengthens Leadership with Dr. Ken Massey as Operations Advisor #USA #Detroit #Drug_Development #SciTech_Development #Ken_Massey

0 0 0 0
Preview
SciTech Development Reports Positive Insights on Phase 1A T-Cell Lymphoma Trial SciTech Development shares positive initial findings from its Phase 1A trial involving T-cell non-Hodgkin lymphoma, highlighting safety and efficacy.

SciTech Development Reports Positive Insights on Phase 1A T-Cell Lymphoma Trial #USA #Detroit #SciTech_Development #ST-001 #T-cell_lymphoma

0 0 0 0